PENTRA

Details for Australian Trade Mark No. 1446877 (hide)

Owner Delenex Therapeutics AG

Convention CH 29 December 2010 614159

Service Refer to WIPO Address for Correspondence

IR Number 1087884

Filing Date 26 April 2011

Classes

Class 1 Chemical products for industrial and scientific purposes, particularly chemical products for biochemical and laboratory purposes and those intended for biotechnological manufacturing; reagents intended for the biochemical industry; all the aforesaid goods being in connection with antibodies and/or antibody mimetics of all kinds

Class 42 Scientific and industrial research and development in connection with biotechnology and biomedicine; chemical, biochemical and biomolecular analyses; in vitro and in vivo preclinical tests in connection with potential medicines; in vitro and in vivo research in connection with the presence and/or functionality of organic and inorganic substances; professional consulting, except business consulting for companies, in connection with the aforesaid analyses, tests and research; all the aforesaid services being in connection with antibodies and/or antibody mimetics of all kinds

Event Publications

15 September 2011 Application filed

12 April 2012 Subsequent Applications/Holder Recorded - Full Assignment

  HORIBA ABX SAS is the full asignee of Delenex Therapeutics AG.

24 May 2012 Subsequent Applications/Holder Recorded - Full Assignment

  Delenex Therapeutics AG is the full asignee of HORIBA ABX SAS.

30 August 2012 Application Accepted

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1446878-ThreatMetrix ExactID

1446876-MICROSOFT BE WHAT'S NEXT.